Published in Brain Res Bull on July 01, 1986
Developmental cholinotoxicants: nicotine and chlorpyrifos. Environ Health Perspect (1999) 2.27
Effects of nicotine during pregnancy: human and experimental evidence. Curr Neuropharmacol (2007) 1.15
Prenatal tobacco exposure: developmental outcomes in the neonatal period. Dev Psychol (2011) 1.03
Developmental nicotine exposure alters neurotransmission and excitability in hypoglossal motoneurons. J Neurophysiol (2010) 0.98
Neurobehavioral phenotype of C57BL/6J mice prenatally and neonatally exposed to cigarette smoke. Neurotoxicol Teratol (2013) 0.85
Early exposure to nicotine during critical periods of brain development: Mechanisms and consequences. J Pediatr Biochem (2010) 0.80
Developmental cigarette smoke exposure: hippocampus proteome and metabolome profiles in low birth weight pups. Toxicology (2014) 0.79
Direct activation of capsaicin receptors by products of lipoxygenases: endogenous capsaicin-like substances. Proc Natl Acad Sci U S A (2000) 4.53
A human RNA polymerase II complex associated with SRB and DNA-repair proteins. Nature (1996) 3.50
Preferential proliferation of natural killer cells among peripheral blood mononuclear cells cocultured with B lymphoblastoid cell lines. Nat Immun Cell Growth Regul (1987) 3.45
Mammalian capping enzyme complements mutant Saccharomyces cerevisiae lacking mRNA guanylyltransferase and selectively binds the elongating form of RNA polymerase II. Proc Natl Acad Sci U S A (1997) 3.14
Detection of Salmonella typhi in the blood of patients with typhoid fever by polymerase chain reaction. J Clin Microbiol (1993) 3.08
The Fc receptor for IgG on human natural killer cells: phenotypic, functional, and comparative studies with monoclonal antibodies. J Immunol (1984) 2.70
Modeling the developmental neurotoxicity of chlorpyrifos in vitro: macromolecule synthesis in PC12 cells. Toxicol Appl Pharmacol (1998) 2.58
Developmental neurotoxicity of chlorpyrifos: cellular mechanisms. Toxicol Appl Pharmacol (1995) 2.47
Cellular mechanisms for developmental toxicity of chlorpyrifos: targeting the adenylyl cyclase signaling cascade. Toxicol Appl Pharmacol (1997) 2.42
Human natural killer cells analyzed by B73.1, a monoclonal antibody blocking Fc receptor functions. II. Studies of B73.1 antibody-antigen interaction on the lymphocyte membrane. J Immunol (1983) 2.37
A novel germ line juxtamembrane Met mutation in human gastric cancer. Oncogene (2000) 2.35
NAT, a human complex containing Srb polypeptides that functions as a negative regulator of activated transcription. Mol Cell (1998) 2.33
Paclitaxel-based chemoradiotherapy in localized gastric carcinoma: degree of pathologic response and not clinical parameters dictated patient outcome. J Clin Oncol (2005) 1.93
Oxidative stress is more important than acid in the pathogenesis of reflux oesophagitis in rats. Gut (2001) 1.90
Persistent behavioral consequences of neonatal chlorpyrifos exposure in rats. Brain Res Dev Brain Res (2001) 1.90
Chlorpyrifos interferes with cell development in rat brain regions. Brain Res Bull (1997) 1.88
Cyclosporin-mediated inhibition of bovine calcineurin by cyclophilins A and B. Proc Natl Acad Sci U S A (1992) 1.85
Chlorpyrifos elicits mitotic abnormalities and apoptosis in neuroepithelium of cultured rat embryos. Teratology (1998) 1.83
The RNA polymerase II general transcription factors: past, present, and future. Cold Spring Harb Symp Quant Biol (1998) 1.82
Snapshot of a large dynamic replicon in a halophilic archaeon: megaplasmid or minichromosome? Genome Res (1998) 1.81
Potent HIV protease inhibitors incorporating high-affinity P2-ligands and (R)-(hydroxyethylamino)sulfonamide isostere. Bioorg Med Chem Lett (1998) 1.75
The human immunodeficiency virus transactivator Tat interacts with the RNA polymerase II holoenzyme. Mol Cell Biol (1997) 1.70
Developmental neurotoxicity of chlorpyrifos: delayed targeting of DNA synthesis after repeated administration. Brain Res Dev Brain Res (1998) 1.60
Cyclin C/CDK8 is a novel CTD kinase associated with RNA polymerase II. Oncogene (1996) 1.58
Chlorpyrifos exposure during a critical neonatal period elicits gender-selective deficits in the development of coordination skills and locomotor activity. Brain Res Dev Brain Res (2000) 1.58
Developmental neurotoxicity of chlorpyrifos modeled in vitro: comparative effects of metabolites and other cholinesterase inhibitors on DNA synthesis in PC12 and C6 cells. Environ Health Perspect (2001) 1.57
An animal model of adolescent nicotine exposure: effects on gene expression and macromolecular constituents in rat brain regions. Brain Res (2000) 1.51
Human cyclin-dependent kinase-activating kinase exists in three distinct complexes. Proc Natl Acad Sci U S A (1996) 1.49
Early biochemical detection of delayed neurotoxicity resulting from developmental exposure to chloropyrifos. Brain Res Bull (1998) 1.48
Neonatal chlorpyrifos exposure alters synaptic development and neuronal activity in cholinergic and catecholaminergic pathways. Brain Res Dev Brain Res (1999) 1.48
A New Statistical Model Identified Two-thirds of Clinical T1 Gastric Cancers as Possible Candidates for Endoscopic Treatment. Ann Surg Oncol (2015) 1.41
Adolescent nicotine exposure causes persistent upregulation of nicotinic cholinergic receptors in rat brain regions. Brain Res (1999) 1.40
Persistent cholinergic presynaptic deficits after neonatal chlorpyrifos exposure. Brain Res (2001) 1.39
Comparing the efficacy of staff versus housestaff instruction in an intervention to improve hypertension management. Acad Med (2001) 1.38
Fetal and adolescent nicotine administration: effects on CNS serotonergic systems. Brain Res (2001) 1.36
Oxidative damages are critical in pathogenesis of reflux esophagitis: implication of antioxidants in its treatment. Free Radic Biol Med (2001) 1.35
The "stress" of being born. Sci Am (1986) 1.35
Developmental neurotoxicity of chlorpyrifos in vivo and in vitro: effects on nuclear transcription factors involved in cell replication and differentiation. Brain Res (2000) 1.34
Adrenomedullary function in the neonatal rat: responses to acute hypoxia. J Physiol (1985) 1.32
NAD+-linked 15-hydroxyprostaglandin dehydrogenase: structure and biological functions. Curr Pharm Des (2006) 1.31
Fetal risk of anesthesia and surgery during pregnancy. Anesthesiology (1986) 1.31
Analysis of the interaction of the novel RNA polymerase II (pol II) subunit hsRPB4 with its partner hsRPB7 and with pol II. Mol Cell Biol (1998) 1.30
Functional alterations in CNS catecholamine systems in adolescence and adulthood after neonatal chlorpyrifos exposure. Brain Res Dev Brain Res (2002) 1.29
Cloning, sequencing, and characterization of Escherichia coli thioesterase II. J Biol Chem (1991) 1.28
Association between SNPs and gene expression in multiple regions of the human brain. Transl Psychiatry (2012) 1.27
Carboxyl terminus of inducible nitric oxide synthase. Contribution to NADPH binding and enzymatic activity. J Biol Chem (1994) 1.26
Beta-adrenoceptor signaling and its control of cell replication in MDA-MB-231 human breast cancer cells. Breast Cancer Res Treat (2000) 1.25
Resolvin D1 attenuates activation of sensory transient receptor potential channels leading to multiple anti-nociception. Br J Pharmacol (2010) 1.23
Prevalence, persistence, and correlates of depressive symptoms in a national sample of mothers of toddlers. J Am Acad Child Adolesc Psychiatry (2001) 1.23
Adolescent nicotine exposure produces immediate and long-term changes in CNS noradrenergic and dopaminergic function. Brain Res (2001) 1.21
Fidelity of implementation in a treatment effectiveness trial of Reconnecting Youth. Health Educ Res (2006) 1.21
Is oxidative stress involved in the developmental neurotoxicity of chlorpyrifos? Brain Res Dev Brain Res (2000) 1.20
The general transcription factors IIA, IIB, IIF, and IIE are required for RNA polymerase II transcription from the human U1 small nuclear RNA promoter. Mol Cell Biol (1999) 1.18
The hepatitis B virus encoded oncoprotein pX amplifies TGF-beta family signaling through direct interaction with Smad4: potential mechanism of hepatitis B virus-induced liver fibrosis. Genes Dev (2001) 1.17
Pulse error compensating symmetric magic-echo trains. J Magn Reson (2003) 1.13
Signaling pathways mediating insulin-stimulated glucose transport. Ann N Y Acad Sci (1999) 1.13
Adrenomedullary catecholamine release in the fetus and newborn: secretory mechanisms and their role in stress and survival. J Dev Physiol (1988) 1.13
Effects of prenatal nicotine exposure on development of central and peripheral cholinergic neurotransmitter systems. Evidence for cholinergic trophic influences in developing brain. J Pharmacol Exp Ther (1989) 1.13
Involvement of oxidative stress in experimentally induced reflux esophagitis and Barrett's esophagus: clue for the chemoprevention of esophageal carcinoma by antioxidants. Mutat Res (2001) 1.12
Expression of specific high capacity mevalonate transport in a Chinese hamster cell variant. J Biol Chem (1987) 1.11
17(R)-resolvin D1 specifically inhibits transient receptor potential ion channel vanilloid 3 leading to peripheral antinociception. Br J Pharmacol (2012) 1.11
Impaired cardiac function during postnatal hypoxia in rats exposed to nicotine prenatally: implications for perinatal morbidity and mortality, and for sudden infant death syndrome. Teratology (1997) 1.10
G13alpha-mediated PYK2 activation. PYK2 is a mediator of G13alpha -induced serum response element-dependent transcription. J Biol Chem (2000) 1.10
Perinatal exposure to environmental tobacco smoke upregulates nicotinic cholinergic receptors in monkey brain. Brain Res Dev Brain Res (2002) 1.09
Prenatal exposure to nicotine impairs nervous system development at a dose which does not affect viability or growth. Brain Res Bull (1989) 1.09
Vaccine-induced cytokine responses in a guinea pig model of pulmonary tuberculosis. Tuberculosis (Edinb) (2005) 1.07
Production and characterization of guinea pig recombinant gamma interferon and its effect on macrophage activation. Infect Immun (2006) 1.07
Odorants differentially enhance phosphoinositide turnover and adenylyl cyclase in olfactory receptor neuronal cultures. J Neurosci (1993) 1.07
Osteoprotegerin and osteoprotegerin ligand effects on osteoclast formation from human peripheral blood mononuclear cell precursors. J Cell Biochem (1999) 1.07
Persistent and delayed behavioral changes after nicotine treatment in adolescent rats. Brain Res (2000) 1.06
Rictor regulates cell migration by suppressing RhoGDI2. Oncogene (2012) 1.06
Structure based design: novel spirocyclic ethers as nonpeptidal P2-ligands for HIV protease inhibitors. Bioorg Med Chem Lett (1998) 1.05
Nicotine evokes cell death in embryonic rat brain during neurulation. J Pharmacol Exp Ther (1998) 1.05
Neonatal chlorpyrifos exposure targets multiple proteins governing the hepatic adenylyl cyclase signaling cascade: implications for neurotoxicity. Brain Res Dev Brain Res (2000) 1.05
Loss of neonatal hypoxia tolerance after prenatal nicotine exposure: implications for sudden infant death syndrome. Brain Res Bull (1995) 1.05